Evidence map›Paper›PMID 29456136›Full record

ArticleDevelopmental cell2018

A Sex Chromosome piRNA Promotes Robust Dosage Compensation and Sex Determination in C. elegans.

Wen Tang, Meetu Seth, Shikui Tu, En-Zhi Shen, Qian Li, Masaki Shirayama, Zhiping Weng, Craig C Mello

Abstract read
In one paragraph

Article in Developmental cell, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Insights in piRNA targeting rules.Wiley interdisciplinary reviews. RNA · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Wen TangRNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA 01605, USA.
Meetu SethRNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA 01605, USA.
Shikui TuProgram in Bioinformatics and Integrative Biology, University of Massachusetts Medical School, Worcester, MA 01605, USA.
En-Zhi ShenRNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA 01605, USA.
Qian LiRNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA 01605, USA.
Masaki ShirayamaRNA Therapeutics Institute, Howard Hughes Medical Institute, University of Massachusetts Medical School, Worcester, MA 01605, USA.
Zhiping WengProgram in Bioinformatics and Integrative Biology, University of Massachusetts Medical School, Worcester, MA 01605, USA.
Craig C MelloRNA Therapeutics Institute, Howard Hughes Medical Institute, University of Massachusetts Medical School, Worcester, MA 01605, USA. Electronic address: craig.mello@umassmed.edu.

Funding

Enhancing and expanding the CGC Strain CollectionP40OD010440 · OD · UNIVERSITY OF MINNESOTA · PI Aric L Daul, Ann E. Rougvie · 2012 to 2026
$7.5M
Understanding the architecture, regulation, and function of piRNA-producing genesP01HD078253 · NICHD · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI ZAMORE, PHILLIP D · 2015 to 2019
$6.5M
RNA MEDIATED GENETIC INTERFERENCE IN C ELEGANSR01GM058800 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI MELLO, CRAIG C · 1999 to 2014
$4.6M
RNA Mediated Genetic Interference in C. elegansR37GM058800 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI MELLO, CRAIG C · 2015 to 2024
$3.7M
Biogenesis of piRNA and its function in endogenous gene regulationR00GM124460 · NIGMS · OHIO STATE UNIVERSITY · PI TANG, WEN · 2019 to 2021
$747k
Biogenesis of piRNA and its function in endogenous gene regulationK99GM124460 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI TANG, WEN · 2017 to 2018
$180k
Howard Hughes Medical InstituteNICHD NIH HHS P01 HD078253NIGMS NIH HHS K99 GM124460NIGMS NIH HHS R00 GM124460NIGMS NIH HHS R01 GM058800NIGMS NIH HHS R37 GM058800NIH HHS P40 OD010440
6 · The paper itself

Abstract

In metazoans, Piwi-related Argonaute proteins engage piRNAs (Piwi-interacting small RNAs) to defend the genome against invasive nucleic acids, such as transposable elements. Yet many organisms-including worms and humans-express thousands of piRNAs that do not target transposons, suggesting that piRNA function extends beyond genome defense. Here, we show that the X chromosome-derived piRNA 21ux-1 downregulates XOL-1 (XO Lethal), a master regulator of X chromosome dosage compensation and sex determination in Caenorhabditis elegans. Mutations in 21ux-1 and several Piwi-pathway components sensitize hermaphrodites to dosage compensation and sex determination defects. We show that the piRNA pathway also targets xol-1 in C. briggsae, a nematode species related to C. elegans. Our findings reveal physiologically important piRNA-mRNA interactions, raising the possibility that piRNAs function broadly to ensure robust gene expression and germline development.

Indexed as

Dosage Compensation, GeneticGene Expression RegulationSex ChromosomesSex Determination AnalysisAnimalsCaenorhabditis elegansCaenorhabditis elegans ProteinsPhenotypeRNA, Small InterferingCaenorhabditis elegans ProteinsRNA, Small InterferingCaenorhabditis briggsaeCaenorhabditis elegansdosage compensationpiRNAssex determinationsmall RNAs

Identifiers

PMID29456136
PMCPMC5991626

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.